What is the prevalence of Pancreatic cancer?

Pancreatic cancer is not classified as a rare disease, with an estimated global incidence of approximately 495,000 new cases annually according to GLOBOCAN data. While prevalence is difficult to determine precisely due to high mortality rates, it remains a significant global health challenge that typically affects adults over the age of 60.

Is pancreatic cancer considered a rare disease?

Unlike rare diseases defined by low prevalence, pancreatic cancer is considered a common malignancy in global oncology. However, specific rare subtypes, such as pancreatic neuroendocrine tumors (pNETs), do fall under the rare disease classification. Data from the DiseaseMaps.org community reflects this, as 32 individuals currently share their experiences with pancreatic cancer on our platform, highlighting the need for collective support.

How does age and gender impact pancreatic cancer incidence?

The risk of developing pancreatic cancer increases significantly with age; the median age at diagnosis is approximately 70 years. While it can occur in younger adults, it is extremely rare in pediatric populations. Regarding gender, pancreatic cancer is slightly more common in males than in females, a trend observed consistently across most ethnic groups and geographic regions.

What factors influence the prevalence of pancreatic cancer?

Accurate prevalence data for pancreatic cancer is often challenged by the aggressive nature of the disease and the fact that many cases are diagnosed at an advanced stage. Variations in reporting and access to diagnostic imaging contribute to discrepancies in global statistics. Key demographic and risk factors include:

• Age: Most diagnoses occur between ages 65 and 74.


• Tobacco Use: Smoking is a major preventable risk factor, accounting for approximately 20-25% of cases.


• Genetic Predisposition: Approximately 5-10% of pancreatic cancer cases are linked to inherited genetic syndromes.


• Ethnicity: Higher incidence rates have been documented in African American populations compared to other ethnic groups in the United States.

Next steps

• Consult a gastroenterologist or oncologist if you have concerns regarding persistent abdominal symptoms or family history.


• Connect with the 32 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Review clinical trial opportunities through the National Cancer Institute (NCI) for the latest research on pancreatic cancer treatment.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding any medical condition.

References

• American Cancer Society: Cancer Facts & Figures 2024.


• GLOBOCAN (Global Cancer Observatory): Pancreatic Cancer Incidence Data.


• NIH National Cancer Institute (NCI): PDQ® Pancreatic Cancer Treatment Information.


• Pancreatic Cancer Action Network (PanCAN): Patient Services and Research Data.